Global Cord Blood (NYSE:CORBF) versus agilon health (NYSE:AGL) Financial Contrast

agilon health (NYSE:AGL) and Global Cord Blood (NYSE:CORBF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Risk & Volatility

agilon health has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500.

Profitability

This table compares agilon health and Global Cord Blood’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
agilon health	-5.76%	-21.74%	-8.89%
Global Cord Blood	N/A	N/A	N/A

Earnings & Valuation

This table compares agilon health and Global Cord Blood’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
agilon health	$4.32 billion	0.49	-$262.60 million	($0.65)	-7.95
Global Cord Blood	$196.12 million	N/A	$79.04 million	N/A	N/A

Global Cord Blood has lower revenue, but higher earnings than agilon health.

Analyst Ratings

This is a summary of current recommendations and price targets for agilon health and Global Cord Blood, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
agilon health	1	12	4	0	2.18
Global Cord Blood	0	0	0	0	N/A

agilon health currently has a consensus target price of $9.46, suggesting a potential upside of 83.24%. Given agilon health’s higher possible upside, research analysts plainly believe agilon health is more favorable than Global Cord Blood.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.